EdgeRock Capital’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
EdgeRock Capital's OGN Position: Q3 2024 in Review
EdgeRock Capital sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 14 shares — an estimated $289 sold.
EdgeRock Capital first reported a position in OGN in Q3 2022 and held it in 3 quarters. The position peaked at $289 in Q2 2024. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.
- EdgeRock Capital reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
- EdgeRock Capital sold 14 Organon & Co shares in Q3 2024, an estimated $289.
- EdgeRock Capital first reported a position in Organon & Co in Q3 2022 and held it in 3 quarters.
- EdgeRock Capital's Organon & Co position peaked at $289 in Q2 2024.
- 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.
Based on EdgeRock Capital's 13F filing for Q3 2024, filed 15 Oct 2024.